Who founded R3 Vascular?

R3 Vascular was founded by Kamal Ramzipoor in 2019.

Who are R3 Vascular's investors?

R3 Vascular's investors include 415 Capital.

How much funding has R3 Vascular raised?

R3 Vascular has disclosed $75.2M raised across 2 rounds.

Where is R3 Vascular headquartered?

R3 Vascular is headquartered in Mountain View, US.

R3 Vascular

Mountain View, US · Founded 2019 · Delaware corporation · 1 known investors

R3 Vascular develops bioresorbable vascular scaffolds made from a proprietary polymer using a proprietary manufacturing process. It operates in the medical device field for vascular treatment.

Biotech Healthtech Medical Devices New Materials

Founders & leadership

R3 Vascular was founded in 2019 by Kamal Ramzipoor.

Kamal RamzipoorinCTO, Founder

Christopher M. OwensPresident and Chief Executive Officer

Mahmood RazaviNamed on SEC filing

JeanMarie MarkhamNamed on SEC filing

Board

Frederik Groenewegen inBoard directorGeneral Partner at 415 Capital

John SpringerBoard director

Michael HurleyBoard director

David NeustaedterBoard director

Nathan HarringtonBoard director

Amir AbolfathiBoard director

Investors · 1

415 CapitalMunich · $5.4M – $16.2M

Reported raises · per SEC filings

Form D private placements

$75.2M disclosed across 2 rounds · 2019–2024

▶$72.5MraisedSep 2024 · 34 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Kamal RamzipoorExecutive Officer
Frederik GroenewegenDirector
John SpringerDirector
Michael HurleyDirector
David NeustaedterDirector
Christopher M. OwensExecutive Officer, Director
Amir AbolfathiDirector
Nathan HarringtonDirector

Amount sold: $72.5M
Minimum investment: $331
First sale: Apr 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.7MraisedMay 2020 · 23 investors · Other Health Care

Rule 506(c)

Officers, directors & promoters on the filing

Kamal RamzipoorDirector
Mahmood RazaviDirector
JeanMarie MarkhamDirector
John SpringerExecutive Officer, Director

Offering amount: $3M
Amount sold: $2.7M
Minimum investment: $25K
Sales commissions: $15K
Proceeds to insiders: $450K
Placement agents: Beech Hill Securities, Inc
First sale: Aug 2019
Incorporated: Corporation, California, 2019
Federal exemptions: 04, 06c

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

R37 shared keywordsEnterprise blockchain/distributed ledger technology company led by David Rutter.

Companies competing with R3 Vascular for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

R3 Vascular Raises $87M in Series B Financingfinsmes.com · May 2024

R3 Vascular raises $87M to test its bioresorbable scaffold for blocked arteries below the kneefiercebiotech.com · May 2024

R3 Vascular secures funding to support bioresorbable scaffold trialfinance.yahoo.com · May 2024

Bioresorbable scaffold maker R3 Vascular raises $87M, names new CEOmassdevice.com · May 2024

R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEOglobenewswire.com · May 2024

Frequently asked questions

What does R3 Vascular do?: R3 Vascular develops bioresorbable vascular scaffolds made from a proprietary polymer using a proprietary manufacturing process. It operates in the medical device field for vascular treatment.
Who founded R3 Vascular?: R3 Vascular was founded by Kamal Ramzipoor in 2019.
Who are R3 Vascular's investors?: R3 Vascular's investors include 415 Capital.
How much funding has R3 Vascular raised?: R3 Vascular has disclosed $75.2M raised across 2 rounds.
Where is R3 Vascular headquartered?: R3 Vascular is headquartered in Mountain View, US.